Materiality pending
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
- Collegium Pharmaceutical reported earnings of $1.45 per share, missing estimates. - Revenue for the quarter was $144.92 million, slightly below expectations. - Stock performance has outpaced the S&P 500, gaining 23.7%. - Earnings outlook is mixed, with a Zacks Rank #3 (Hold). - Industry rank for Medical - Drugs is in the top 40%. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings
- Collegium Pharmaceutical reported earnings of $1.45 per share, missing estimates.
- Revenue for the quarter was $144.92 million, slightly below expectations.
- Stock performance has outpaced the S&P 500, gaining 23.7%.
- Earnings outlook is mixed, with a Zacks Rank #3 (Hold).
- Industry rank for Medical - Drugs is in the top 40%.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.